In Management of Uncontrolled Type-2 Diabetes with CV Complications
Gliclazide (Extended Release) 60 mg Tablets
The Time Tested & Assured SU
- Provides effective glycemic control irrespective of BMI
- Least risk of hypo & without weight gain
-
Significantly reduces vascular complications
-
Preserves beta cell through anti-oxidant properties
In Obese Uncontrolled Type-2 Diabetes with CV Complications
Gliclazide 60 mg, Metrformin Hydrochloride 500 mg (Extended Release)
The Time Tested & Trusted Combination
- Ensures cardiovascular protection unlike glimepiride
- Preserves beta cell through anti-oxidant properties
-
As per the FACT study, Gliclazide reduces HbA1c by - 1.9% in 6 months with least hypoglycemia as well as no weight gain
